{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:19:37Z","timestamp":1786760377222,"version":"build-2736575974"},"reference-count":65,"publisher":"The Endocrine Society","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PRIN","award":["P2022Z4EB5_002"],"award-info":[{"award-number":["P2022Z4EB5_002"]}]},{"name":"Department of Health Science"},{"name":"DISS"},{"DOI":"10.13039\/501100005699","name":"Universit\u00e0 del Piemonte Orientale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005699","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Partial lipodystrophies (PLD) can closely mimic the clinical presentation of Cushing syndrome (CS). Simplified risk scores have been developed to estimate the clinical probability of CS. However, their ability to discriminate CS from overlapping conditions such as PLD remains unclear. Moreover, reduced leptin action in lipodystrophy may influence the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis, although human data are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare clinical and metabolic features of PLD and CS, evaluate the discriminatory ability of clinical risk scores for CS, and explore leptin\u2013HPA axis interactions in PLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective multicenter study including 61 patients with PLD and 56 patients with CS. Clinical and laboratory data were retrieved from medical records. Two clinical risk score for CS were calculated, and PLD and CS features were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Most PLD patients showed at least one feature suggestive of hypercortisolism. Facial fullness, facial plethora, dorsocervical fat pad, and hirsutism (P &amp;lt; .001, P = .049, P &amp;lt; .001, and P &amp;lt; .001, respectively) were more frequent in PLD, while proximal muscle atrophy and osteoporosis (P &amp;lt; .001 and P = .010) were more common in CS. Higher rates of diabetes and hypertriglyceridemia were also observed in PLD (P &amp;lt; .001). PLD patients achieved similar or even higher clinical CS score values than CS patients. In multivariable regression analysis, proximal muscle atrophy and osteoporosis were associated with CS (P &amp;lt; .04), whereas diabetes and hypertriglyceridemia were associated with PLD (both P &amp;lt; .001). No correlation was found between leptin levels and glucocorticoid-related hormonal parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PLD patients often exhibit cushingoid features, limiting the specificity of simplified clinical risk scores for CS. Increased awareness of lipodystrophy phenotypes and their distinguishing features is essential to reduce misdiagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgag314","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:45:57Z","timestamp":1785843957000},"source":"Crossref","is-referenced-by-count":1,"title":["Partial lipodystrophy mimicking Cushing syndrome: clinical and metabolic insights from a multicenter study"],"prefix":"10.1210","author":[{"given":"Stella","family":"Pigni","sequence":"first","affiliation":[{"name":"Department of Translational Medicine, University of Eastern Piedmont , 28100 Novara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Cecchetti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , 40138 Bologna ,","place":["Italy"]},{"name":"Endocrinology Unit, Ospedale Morgagni-Pierantoni , 47121 Forl\u00ec ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Caputo","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Eastern Piedmont , 28100 Novara ,","place":["Italy"]},{"name":"Endocrinology Unit, University Hospital \u201cMaggiore della Carit\u00e0\u201d , 28100 Novara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0393-2280","authenticated-orcid":false,"given":"Laura","family":"Rotolo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , 40138 Bologna ,","place":["Italy"]},{"name":"Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna , 40138 Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-8394","authenticated-orcid":false,"given":"Maria Francesca","family":"Birtolo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , 20072 Pieve Emanuele (Milan) ,","place":["Italy"]},{"name":"Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital , 20089 Rozzano (Milan) ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Pelosini","sequence":"additional","affiliation":[{"name":"Chemistry and Endocrinology Laboratory, University Hospital of Pisa , 56124 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Giordano","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Eastern Piedmont , 28100 Novara ,","place":["Italy"]},{"name":"Unit of Genetics, Clinical Biochemistry, University Hospital \u201cMaggiore Della Carit\u00e0\u201d , 28100 Novara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5458-701X","authenticated-orcid":false,"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , 20072 Pieve Emanuele (Milan) ,","place":["Italy"]},{"name":"Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital , 20089 Rozzano (Milan) ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lania","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , 20072 Pieve Emanuele (Milan) ,","place":["Italy"]},{"name":"Endocrinology, Diabetology and Andrology Unit, IRCCS Humanitas Research Hospital , 20089 Rozzano (Milan) ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2242-6734","authenticated-orcid":false,"given":"Alessandra","family":"Gambineri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna , 40138 Bologna ,","place":["Italy"]},{"name":"Division of Endocrinology and Diabetes Prevention and Care, IRCCS Azienda Ospedaliero-Universitaria di Bologna , 40138 Bologna ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-5335","authenticated-orcid":false,"given":"Flavia","family":"Prodam","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University of Eastern Piedmont , 28100 Novara ,","place":["Italy"]},{"name":"Endocrinology Unit, University Hospital \u201cMaggiore della Carit\u00e0\u201d , 28100 Novara ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"12","key":"2026081411220592500_dgag314-B1","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081411220592500_dgag314-B2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40618-018-0887-z","article-title":"Diagnosis and treatment of lipodystrophy: a step-by-step approach","volume":"42","author":"Ara\u00fajo-Vilar","year":"2019","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2026081411220592500_dgag314-B3","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1210\/clinem\/dgac079","article-title":"Approach to the patient with lipodystrophy","volume":"107","author":"Fourman","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026081411220592500_dgag314-B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-025-01603-4","article-title":"Clinical guidance for lipodystrophy syndromes: from diagnosis and work-up to treatment","volume":"25","author":"Gilio","year":"2025","journal-title":"Curr Diab Rep"},{"issue":"2","key":"2026081411220592500_dgag314-B5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/db19-0447","article-title":"Clinical and molecular prevalence of lipodystrophy in an unascertained large clinical care cohort","volume":"69","author":"Gonzaga-Jauregui","year":"2020","journal-title":"Diabetes"},{"issue":"7","key":"2026081411220592500_dgag314-B6","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/dbi24-0018","article-title":"Lipodystrophy prevalence, \u201clipodystrophy-like phenotypes,\u201d and diagnostic challenges","volume":"73","author":"Akinci","year":"2024","journal-title":"Diabetes"},{"issue":"3","key":"2026081411220592500_dgag314-B7","first-page":"907","article-title":"Lipodistrophy: a paradigm for understanding the consequences of \u201coverloading\u201d adipose tissue","volume":"101","author":"Lim","year":"2021","journal-title":"Physiol Rev"},{"issue":"1","key":"2026081411220592500_dgag314-B8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.metabol.2014.08.004","article-title":"Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism","volume":"64","author":"Park","year":"2015","journal-title":"Metabolism"},{"key":"2026081411220592500_dgag314-B9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.803189","article-title":"Molecular and cellular bases of lipodystrophy syndromes","volume":"12","author":"Zammouri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2026081411220592500_dgag314-B10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11892-018-1099-9","article-title":"Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities","volume":"18","author":"Akinci","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"1","key":"2026081411220592500_dgag314-B11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11892-025-01602-5","article-title":"Lipodystrophy syndromes: one name but many diseases highlighting the importance of adipose tissue in metabolism","volume":"25","author":"Foss-Freitas","year":"2025","journal-title":"Curr Diab Rep"},{"issue":"2","key":"2026081411220592500_dgag314-B12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/17446651.2020.1735360","article-title":"Diagnostic strategies and clinical management of lipodystrophy","volume":"15","author":"Foss-Freitas","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"3","key":"2026081411220592500_dgag314-B13","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2021.104071","article-title":"Familial partial lipodystrophy syndromes","volume":"50","author":"Fern\u00e1ndez-Pombo","year":"2021","journal-title":"Presse Med"},{"issue":"5","key":"2026081411220592500_dgag314-B14","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1093\/ejendo\/lvag067","article-title":"Lipodystrophy look-alikes: navigating diagnostic overlap with endocrine diseases","volume":"194","author":"Ceccarini","year":"2026","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026081411220592500_dgag314-B15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2026081411220592500_dgag314-B16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"2026081411220592500_dgag314-B17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fendo.2019.00766","article-title":"Toward a diagnostic score in Cushing's syndrome","volume":"10","author":"Braun","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026081411220592500_dgag314-B18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.747549","article-title":"A new clinical model to estimate the pre-test probability of Cushing's syndrome: the Cushing score","volume":"12","author":"Parasiliti-Caprino","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026081411220592500_dgag314-B19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11102-025-01583-4","article-title":"Development and validation of clinical screening systems for Cushing disease in the United States","volume":"28","author":"Salcedo-Sifuentes","year":"2025","journal-title":"Pituitary"},{"issue":"27","key":"2026081411220592500_dgag314-B20","doi-asserted-by":"crossref","first-page":"13670","DOI":"10.1073\/pnas.1901795116","article-title":"Leptin's hunger-suppressing effects are mediated by the hypothalamic-pituitary-adrenocortical axis in rodents","volume":"116","author":"Perry","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"2026081411220592500_dgag314-B21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nm.3579","article-title":"Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis","volume":"20","author":"Perry","year":"2014","journal-title":"Nat Med"},{"key":"2026081411220592500_dgag314-B22","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156026","article-title":"History and future of leptin: discovery, regulation and signaling","volume":"161","author":"M\u00fcnzberg","year":"2024","journal-title":"Metabolism"},{"key":"2026081411220592500_dgag314-B23","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1151873","article-title":"Across-species benefits of adrenalectomy on congenital generalized lipoatrophic diabetes: a review","volume":"14","author":"Contreras","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2026081411220592500_dgag314-B24","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026081411220592500_dgag314-B25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026081411220592500_dgag314-B26","doi-asserted-by":"crossref","unstructured":"Pigni S, Cecchetti C, Caputo M, et al \u00a0Partial lipodystrophy mimicking Cushing's syndrome: clinical and metabolic insights from a multicenter study - Supplementary data. Zenodo. Published online 2026. 10.5281\/zenodo.21653630","DOI":"10.1210\/clinem\/dgag314"},{"issue":"5","key":"2026081411220592500_dgag314-B27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"Suppl 1","key":"2026081411220592500_dgag314-B28","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"6","key":"2026081411220592500_dgag314-B29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jacl.2022.09.006","article-title":"A mechanism-based operational definition and classification of hypercholesterolemia","volume":"16","author":"Civeira","year":"2022","journal-title":"J Clin Lipidol"},{"issue":"38","key":"2026081411220592500_dgag314-B30","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"2026081411220592500_dgag314-B31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"issue":"10","key":"2026081411220592500_dgag314-B32","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1210\/jc.2016-1673","article-title":"A probabilistic model for Cushing's syndrome screening in at-risk populations: a prospective multicenter study","volume":"101","author":"Le\u00f3n-Justel","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026081411220592500_dgag314-B33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12020-016-1002-x","article-title":"Type 1 familial partial lipodystrophy: understanding the K\u00f6bberling syndrome","volume":"54","author":"Guill\u00edn-Amarelle","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"2026081411220592500_dgag314-B34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13023-023-03004-w","article-title":"Impact of lipodystrophy on health-related quality of life: the QuaLip study","volume":"19","author":"Demir","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2026081411220592500_dgag314-B35","doi-asserted-by":"crossref","first-page":"e2532","DOI":"10.1210\/clinem\/dgae837","article-title":"Health-related quality of life, social, and psychological well-being of 109 adult patients with genetic lipodystrophy","volume":"110","author":"Mosbah","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026081411220592500_dgag314-B36","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/clinem\/dgaf103","article-title":"Lipodystrophy severity score to assess disease burden in lipodystrophy","volume":"110","author":"Brown","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026081411220592500_dgag314-B37","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/jc.2018-02730","article-title":"Comorbidities and survival in patients with lipodystrophy: an international chart review study","volume":"104","author":"Akinci","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026081411220592500_dgag314-B38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/cen.13311","article-title":"Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort","volume":"86","author":"Ajluni","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2026081411220592500_dgag314-B39","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1250203","article-title":"Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain","volume":"14","author":"Fern\u00e1ndez-Pombo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026081411220592500_dgag314-B40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12902-024-01629-x","article-title":"Prevalence of clinical characteristics of lipodystrophy in the US adult population in a healthcare claims database","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2026081411220592500_dgag314-B41","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ejendo\/lvaf214","article-title":"Epidemiological and clinical data from the European Lipodystrophy Registry","volume":"193","author":"Ceccarini","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026081411220592500_dgag314-B42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1210\/clinem\/dgaf315","article-title":"Clinical features, metabolic and autoimmune derangements in acquired partial lipodystrophy (Barraquer-Simons syndrome)","volume":"111","author":"Kaewkrasaesin","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026081411220592500_dgag314-B43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11892-022-01485-w","article-title":"Lipodystrophy for the diabetologist-what to look for","volume":"22","author":"Patni","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"10","key":"2026081411220592500_dgag314-B44","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1210\/jc.2015-2497","article-title":"Facial plethora: modern technology for quantifying an ancient clinical sign and its use in Cushing syndrome","volume":"100","author":"Afshari","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026081411220592500_dgag314-B45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s42000-022-00386-7","article-title":"Lipodystrophy-associated progeroid syndromes","volume":"21","author":"Ara\u00fajo-Vilar","year":"2022","journal-title":"Hormones (Athens)"},{"issue":"3","key":"2026081411220592500_dgag314-B46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40618-025-02758-3","article-title":"Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of Endocrinology","volume":"49","author":"Ceccato","year":"2026","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2026081411220592500_dgag314-B47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jocd.2016.10.002","article-title":"Bone density in patients with Berardinelli-Seip congenital lipodystrophy is higher in trabecular sites and in type 2 patients","volume":"21","author":"Lima","year":"2018","journal-title":"J Clin Densitom"},{"key":"2026081411220592500_dgag314-B48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bone.2017.03.053","article-title":"Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy","volume":"101","author":"Lima","year":"2017","journal-title":"Bone"},{"key":"2026081411220592500_dgag314-B49","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1326700","article-title":"Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2","volume":"15","author":"Freire","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026081411220592500_dgag314-B50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/cen.13504","article-title":"Bone mineral density in familial partial lipodystrophy","volume":"88","author":"Fern\u00e1ndez-Pombo","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"17","key":"2026081411220592500_dgag314-B51","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713118","article-title":"Refining evaluation of bone mass and adipose distribution in Dunnigan syndrome","volume":"24","author":"Moreira","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2026081411220592500_dgag314-B52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch Osteoporos"},{"issue":"4","key":"2026081411220592500_dgag314-B53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11102-005-1051-2","article-title":"Cushing's syndrome and bone","volume":"7","author":"Mancini","year":"2004","journal-title":"Pituitary"},{"issue":"3","key":"2026081411220592500_dgag314-B54","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-07-0137","article-title":"Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism","volume":"157","author":"Tauchmanov\u00e0","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026081411220592500_dgag314-B55","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status","volume":"91","author":"Tauchmanov\u00e0","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2026081411220592500_dgag314-B56","first-page":"23","article-title":"Screening for endogenous hypercortisolism in patients with osteoporosis and fractures: why, when and how","volume":"48","author":"Giordano","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026081411220592500_dgag314-B57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1043-2760(00)00234-4","article-title":"Glucocorticoid-induced osteoporosis","volume":"11","author":"Manelli","year":"2000","journal-title":"Trends Endocrinol Metab"},{"key":"2026081411220592500_dgag314-B58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000443866","article-title":"Skeletal fragility in endogenous hypercortisolism","volume":"46","author":"Mazziotti","year":"2016","journal-title":"Front Horm Res"},{"issue":"10","key":"2026081411220592500_dgag314-B59","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.nmd.2017.05.015","article-title":"Clinical spectra of neuromuscular manifestations in patients with lipodystrophy: a multicenter study","volume":"27","author":"Akinci","year":"2017","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"2026081411220592500_dgag314-B60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347462","article-title":"Steroid myopathy: some unresolved issues","volume":"34","author":"Minetto","year":"2011","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"2026081411220592500_dgag314-B61","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3803\/EnM.2021.1069","article-title":"Cushing syndrome associated myopathy: it is time for a change","volume":"36","author":"Reincke","year":"2021","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"6","key":"2026081411220592500_dgag314-B62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1490561","article-title":"Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome","volume":"149","author":"Rockall","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 4","key":"2026081411220592500_dgag314-B63","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ijo.0801493","article-title":"A-ZIP\/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes","volume":"24","author":"Reitman","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"7","key":"2026081411220592500_dgag314-B64","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.2337\/diabetes.51.7.2113","article-title":"Adrenalectomy improves diabetes in A-ZIP\/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity","volume":"51","author":"Haluzik","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"2026081411220592500_dgag314-B65","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag314\/70493637\/dgag314.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgag314\/70493637\/dgag314.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:28:38Z","timestamp":1786721318000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article\/doi\/10.1210\/clinem\/dgag314\/8752459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":65,"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgag314","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"article-number":"dgag314"}}